{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:55Z","timestamp":1790985295886,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.schres.2009.06.008","type":"journal-article","created":{"date-parts":[[2009,7,12]],"date-time":"2009-07-12T04:11:31Z","timestamp":1247371891000},"page":"246-251","source":"Crossref","is-referenced-by-count":22,"title":["Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia"],"prefix":"10.1016","volume":"113","author":[{"given":"Monika","family":"Edlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rettenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Widschwendter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin Ahmadian","family":"Neco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2009.06.008_bib1","series-title":"Practice guidelines for the treatment of patients with schizophrenia","author":"American Psychiatric Association","year":"2008"},{"key":"10.1016\/j.schres.2009.06.008_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0920-9964(97)00131-X","article-title":"Factors influencing relapse in the long-term course of schizophrenia","volume":"28","author":"Ayuso-Gutierrez","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.06.008_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.yic.0000185022.48279.db","article-title":"Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries","volume":"21","author":"Barbui","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.06.008_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/ajp.149.6.844a","article-title":"Patient's opinions concerning side effects of neuroleptics","volume":"149","author":"Buis","year":"1992","journal-title":"Am. J. Psychiatry."},{"issue":"1\u20133","key":"10.1016\/j.schres.2009.06.008_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.schres.2006.04.005","article-title":"Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine","volume":"86","author":"Byerly","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.06.008_bib6","first-page":"40","article-title":"Side effect profiles of new antipsychotic agents","volume":"57","author":"Casey","year":"1996","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2009.06.008_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.schbul.a006920","article-title":"Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles","volume":"28","author":"Covell","year":"2002","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2009.06.008_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.psc.2007.04.001","article-title":"Treatment-resistant schizophrenia","volume":"30","author":"Elkis","year":"2007","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.schres.2009.06.008_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00406-003-0422-9","article-title":"Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders (drug choice, switching and outcome under naturalistic treatment conditions)","volume":"253","author":"Gaebel","year":"2003","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2009.06.008_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.curtheres.2005.10.004","article-title":"Choice of atypical antipsychotic therapy for patients with schizophrenia: an analysis of a medicaid population","volume":"66","author":"Gordon","year":"2005","journal-title":"Curr. Therap. Res."},{"key":"10.1016\/j.schres.2009.06.008_bib11","doi-asserted-by":"crossref","first-page":"1301-1204","DOI":"10.1176\/appi.ajp.161.7.1301","article-title":"Medical decision making in antipsychotic drug choice for schizophrenia","volume":"161","author":"Hamann","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.06.008_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00228-005-0041-7","article-title":"How do psychiatrists choose among different antipsychotics?","volume":"61","author":"Hamann","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2009.06.008_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/ps.2006.57.5.700","article-title":"Psychiatric decision making in the adoption of a new antipsychotic in Germany","volume":"57","author":"Hamann","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2009.06.008_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.2006.00798.x","article-title":"Shared decision making for inpatients with schizophrenia","volume":"114","author":"Hamann","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.06.008_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4088\/JCP.v68n0703","article-title":"Shared decision making and long-term outcome in schizophrenia treatment","volume":"68","author":"Hamann","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.06.008_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2005.06.004","article-title":"Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions","volume":"40","author":"Hoblyn","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2009.06.008_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2009.06.008_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00005053-199411000-00006","article-title":"Five-factor model of schizophrenia","volume":"182","author":"Lindenmayer","year":"1994","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2009.06.008_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0920-9964(94)00041-6","article-title":"Five factor model of schizophrenia: replication across samples","volume":"14","author":"Lindenmayer","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.06.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.schres.2009.06.008_bib21","first-page":"S1","article-title":"How do we choose between atypical antipsychotics? The advantages of amisulpride","volume":"7","author":"Mortimer","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2009.06.008_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10401230701334606","article-title":"Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?","volume":"19","author":"Motlov\u00e1","year":"2007","journal-title":"Ann. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2009.06.008_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/14622416.7.6.863","article-title":"Genetics of antipsychotic treatment emergent weight gain in schizophrenia","volume":"7","author":"M\u00fcller","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.schres.2009.06.008_bib24","series-title":"Schizophrenia, Full national clinical guideline on core interventions in primary and secondary care","author":"National Institute for Clinical Excellence","year":"2008"},{"issue":"Suppl 1","key":"10.1016\/j.schres.2009.06.008_bib25","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.schres.2009.06.008_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ps.55.2.151","article-title":"Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine","volume":"55","author":"Opolka","year":"2004","journal-title":"Psychiatr. Serv."},{"issue":"6","key":"10.1016\/j.schres.2009.06.008_bib27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.pnpbp.2005.03.019","article-title":"The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment","volume":"29","author":"Reynolds","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Suppl.1","key":"10.1016\/j.schres.2009.06.008_bib28","first-page":"S1","article-title":"The usefulness and use of second-generation antipsychotic medications","volume":"15","author":"Sartorius","year":"2002","journal-title":"Curr. Opin. Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2009.06.008_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"Section of Pharmacopsychiatry, World Psychiatric Association. World Psychiatric Association Pharmacopsychiatry Section","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2009.06.008_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","article-title":"Metabolic side effects of antipsychotic medication","volume":"61","author":"Tschoner","year":"2007","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.schres.2009.06.008_bib31","first-page":"881","article-title":"Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients","volume":"28","author":"Svestka","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.schres.2009.06.008_bib32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/bmj.326.7400.1178","article-title":"Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study","volume":"326","author":"Watkins","year":"2003","journal-title":"BMJ"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996409002850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996409002850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T07:21:29Z","timestamp":1545117689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996409002850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0920996409002850"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2009.06.008","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}